## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy grading that generates lesion proposals internally via grade-conditioned CAM evidence maps (GALP module) without requiring external annotations, and fuses these proposals across views using a gated mixture-of-experts mechanism with Top-K weighted cross-view attention (LGRF module). The goal is to close the gap between purely end-to-end models and externally-informed models that require costly lesion/vessel annotations. Evaluated on two multi-view benchmarks (MFIDDR, DRTiD), the lesion-free variant matches or surpasses nearly all end-to-end baselines and several externally-informed methods, demonstrating that self-derived proposals can substantially reduce annotation dependency.

## Strengths

1. **Self-derived proposals match externally-informed methods without costly annotations.** The paper's central claim is empirically supported: in Table 1, "Ours (w/o lesion)" at 83.9% accuracy surpasses all end-to-end baselines (best: ETMC at 81.5%) and matches externally-informed methods such as CVSA (82.6%) and LFMVDR (82.2%). On DRTiD (Table 3), the method achieves 76.0% accuracy, outperforming CrossFIT (75.6%) which uses OD and macula coordinates.

2. **Substantial gains on Grade 4 (proliferative DR), the most challenging class.** Table 2 shows "Ours (with lesion)" achieves 51.6% F1 on Grade 4, dramatically ahead of WGLIN (29.8%) and SMVDR-M (30.4%). Even the lesion-free variant (36.0% F1) outperforms most externally-informed methods on this rare but clinically critical category.

3. **Clean ablation with monotonic degradation.** Table 4 shows that removing GALP drops accuracy by 1.2pp (82.7→83.9), removing the expert pool drops 1.3pp (82.6→83.9), and removing LGRF drops 1.6pp (82.3→83.9). Each removal produces a clear, attributable decrease, providing evidence that both modules contribute positively.

4. **Cross-dataset validation with different configurations.** The method is evaluated on 4-view (224×224) and 2-view (512×512) datasets with different backbone initializations (ImageNet vs. EyePACS), arguing against overfitting to a single setup.

5. **Systematic hyperparameter analysis.** Figure 3 provides a three-way sweep (retention ratio α, activated experts K₂, total experts M) with interpretable optima at intuitive values (α=0.5, K₂=2, M=6), demonstrating the method is not overly sensitive.

## Weaknesses

### Fatal
None.

### Major
None. The method is sound, the experiments are reasonably comprehensive, and the core claims are supported.

### Minor

1. **Missing a pure backbone-controlled baseline.** The paper adopts Swin-B as its backbone but does not include a "Swin-B + simple multi-view fusion" baseline (e.g., GAP + concatenation across views without GALP or LGRF). The weakest ablation (w/o LGRF, 82.3%) still includes GALP and its auxiliary classifiers, so it does not provide a true backbone-only reference point. While the ablations do demonstrate each module's incremental contribution, and while several baselines (e.g., RETFound) also use transformer backbones, a cleaner baseline would fully disentangle backbone strength from module contribution. This is the most significant gap in the experimental analysis.

2. **The "superior interpretability" claim is unsubstantiated.** Contribution (2) claims "superior robustness and interpretability," and Figure 1 frames end-to-end models as having "Lower model interpretability." Yet the paper provides zero qualitative analysis — no visualizations of the Grade-Activated Evidence Maps (GEMs), no examples of what lesion proposals look like, no comparison of proposals against actual lesion locations, no attention maps, no failure-case analysis. The core performance claim does not depend on interpretability, but the claim is made and should be backed.

3. **The "lesion proposal" framing rests on an unvalidated assumption.** The paper assumes that CAM-highlighted regions correspond to lesions ("Since the grade evidence in DR is predominantly localized to lesions"). The MFIDDR dataset includes lesion segmentation masks (as the paper notes). No analysis compares proposals against these masks to confirm they localize microaneurysms, hemorrhages, or exudates. The method works regardless — proposals could be "grade-discriminative regions" rather than lesions — but the terminology makes a stronger claim than is verified.

4. **No statistical significance or variance reported.** All results in Tables 1–4 are single point estimates. Performance margins are small in places (e.g., 83.9% vs. 84.2% with WGLIN), making it difficult to assess whether differences are meaningful or within noise. While single-run evaluation is common on these benchmarks, and many baselines also lack variance estimates, some indication of stability (e.g., mean ± std over seeds) would strengthen confidence.

5. **Focal loss hyperparameters not specified.** The paper uses focal loss for both L_cls and L_aux (Eqs. 2, 19) but does not report γ (focusing parameter) or α (class-balance weight). Focal loss behavior is sensitive to these settings; omitting them reduces reproducibility.

6. **DRTiD comparison partially confounded by domain-specific pretraining.** The method initializes Swin-B on EyePACS (a fundus dataset) for DRTiD, while most baselines (Binocular Network, Cv-Transformer, MVCNN variants, DeepDR) use ImageNet pretraining. However, the comparison with CrossFIT (the strongest baseline at 75.6%) is fair since CrossFIT also uses EyePACS pretraining (the paper explicitly follows CrossFIT's protocol). This partially mitigates the concern.

### Trivial

- The abstract's phrasing "match or surpass strong baselines without external annotations" slightly papers over the 0.3pp gap with WGLIN on MFIDDR accuracy (83.9% vs. 84.2%). The claim is defensible overall but could be more precise.

## Removed Points

The following points from the Harsh Critic were removed after verification against the paper:

- **"Removing all proposed modules (w/o LGRF) still yields 82.3%"** — Factually incorrect. Per the paper (Sec. 4.3), w/o LGRF only removes the fusion module; GALP and its lesion proposals are retained. The ablation removes one of two proposed components, not all modules.

- **Cyclic adjacency not justified** — This is an architectural design choice; the paper is not obligated to exhaustively ablate every design decision, and the method works well as-is.

- **Equation (11) load-balancing ambiguity** — The notation is standard MoE load-balancing loss; the number of "routing decisions" scales with the batch size × number of views, and the formula is conventional.

- **Patch size q dependence as "dataset-specific hack"** — Setting q to evenly divide feature map dimensions is standard practice; this is not a weakness.

- **"The three ablations have similar performance (82.3–82.7%), suggesting the modules are not strongly complementary"** — The 0.4pp spread among ablations is consistent with each module making a modest but measurable contribution. The claim that they are "not complementary" is not supported by the data.

- **Dropped strengths from Strength Finder**: Strengths about addressing an "important problem" are generic and removed. Only concrete, evidence-backed strengths are retained.

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface any novel perspective not already present in the paper's framing and analysis.

## Suggestions

1. **Add a pure Swin-B baseline** with simple multi-view aggregation (e.g., GAP + concatenation across views, no GALP, no LGRF) to Table 4. This would cleanly separate backbone contribution from module contribution.

2. **Provide qualitative evidence** for the interpretability claim: visualize GEMs at different stages, show example lesion proposals overlaid on fundus images, and compare proposals against MFIDDR's available lesion segmentation masks.

3. **Report variance** across 3–5 random seeds for the main results (Tables 1 and 3) to establish statistical reliability.

4. **Either validate or soften the "lesion proposal" terminology.** If proposals are shown to correspond to actual lesions via the MFIDDR masks, keep the framing. Otherwise, replace "lesion proposals" with "grade-discriminative proposals" throughout.

5. **Specify focal loss hyperparameters** (γ and α/β) in the implementation details.

6. **Report FLOPs and parameter counts** so readers can assess the computational cost of the added modules.

## Score and Decision

Given the calibration tool's unavailability, I rely on direct judgment. The paper presents a well-motivated, architecturally coherent method with solid experimental support for its primary claim — that self-derived proposals can substitute for external annotations without significant performance loss. The weaknesses are all in the Minor-to-Trivial range; none threaten the paper's core contributions. The absence of a pure backbone baseline is the most notable gap but does not undermine the ablation evidence showing each module contributes. The paper is clearly above the reject threshold and sits comfortably in the borderline-accept to accept range.

MY FINAL SCORE: <score>7.0</score>
MY FINAL DECISION: <decision>Accept</decision>